share_log

Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology

Rapid Micro Biosystems Announces Publication Of A Multi-Author Case Study Supporting Fully Automated Colony Counting In Pharmaceutical Microbiology

Rapid Micro Biosystems 宣布出版一項多作者案例研究,支持藥物微生物學中的全自動化菌落計數
Benzinga Real-time News ·  2022/12/07 16:31

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company, providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, announced the publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology.

亞洲網加利福尼亞州聖約瑟10月23日電提供關鍵任務自動化解決方案以促進保健產品高效製造和快速、安全釋放的創新生命科學技術公司Rapid Micro BiosSystems,Inc.(納斯達克代碼:RFID)(以下簡稱“本公司”)宣佈出版了一份多作者案例研究報告,該研究報告支持製藥微生物學中的全自動菌落計數。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論